When renal and cardiac insufficiencies intersect: Is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?

European Heart Journal

Volumn 28, Issue 24, 2007, Pages 2960-2961

  Van Kimmenade, Roland R J ^a   Pinto, Yigal ^a   Januzzi Jr , James L ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

BLOOD PRESSURE; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; KIDNEY FUNCTION TESTS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL INSUFFICIENCY; SYNDROME;

EID: 37149008356     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl399     Document Type: Editorial

References (11)

1. Gardner RS, Chong KS, O'Meara E, Jardine A, Ford I, McDonagh TA. Renal dysfunction, as measured by the modification of diet in renal disease (MDRD) equations, and outcome in patients with advanced heart failure. Eur Heart J 2007;28:3027-3033. First Published on October 29, 2007. doi:10.1093/eurheartj/ehm480.
2. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005;26:11-17.
3. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
4. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003;9:13-25.
5. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004;43:61-67.
6. Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 2005;45:1997-2003.
7. Lisy O, Burnett JC Jr. New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing. Circulation 2006;113:246- 251.
8. Stevenson LW, Nohria A, Mielniczuk L. Torrent or torment from the tubules? Challenge of the cardiorenal connections. J Am Coll Cardiol 2005;45:2004-2007.
9. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004;110:1514-1517.
10. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DM, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.
11. van Kimmenade R, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM, Pinto YM. Amino-terminal pro-brain natriuretic peptide, renal function and outcomes in acute heart failure: re-defining the cardio-renal interaction? J Am Coll Cardiol 2006;48:1621-1627.